Cardiac Rhythm Management Devices | Market Insights | Europe (Supplemental) | 2025
The European CRM device market will continue to grow modestly over the forecast period, driven primarily by rising ICM procedure volumes, the introduction of dual-chamber leadless pacemakers, and the increasing adoption of premium-priced devices such as CRT devices, single-chamber leadless pacemakers, and S-ICDs. However, revenue growth will be limited to some extent by ASP declines caused by increasing competition in the leadless pacemaker and S-ICD markets.
This Medtech 360 Report provides comprehensive data and analysis on the state of the European CRM device market from 2019 through 2033.
